2014 CME Symposia - Lunch Symposium A
Register for the CMHC today to sign up for these value-added CME/CE activities-at no additional cost!
Pre-registration for symposia will open at the end of August for CMHC registrants to make selections. There are no additional fees to attend. Symposia include meals or refreshments and seating is limited and on a first-come, first-serve basis.
CME Lunch Symposium A
Thursday · 12:45 - 2:15pm
Obesity Management 2014: New Perspectives and Therapeutic Options for a Growing Problem
Supported by an educational grant from Novo Nordisk, Inc.
Type 2 diabetes and obesity are very much intertwined and treatment of each disease affects the other. This symposium will explore obesity's biologic causes, clinical consequences, and the expanding armamentarium of weight control methods, especially in those special populations affected by prediabetes and diabetes. Clinicians will refine their ability to evaluate comorbidities and select obesity therapies that are safe, effective and individualized for patient needs, and will learn counseling techniques to help patients achieve and maintain their weight loss goals.
- Identify the link between the pathophysiology of obesity and associated comorbid conditions.
- Assess obese patients for intervention based on evidence-based criteria and updated guidelines and develop a risk assessment-based treatment plan.
- Effectively initiate weight-loss discussions with obese patients.
- List physiological factors, signals, and hormones in the gut that regulate satiety/hunger and how they may contribute to obesity.
- Incorporate evidence-based weight loss strategies based on the safety and efficacy profiles of current and emerging anti-obesity medications, so that potential risks and benefits are considered when planning treatment.
Preliminary Agenda & Faculty
|12:45 - 12:55 pm
||Managing Obesity and Comorbid Conditions: Welcome, Introductions and Opening Remarks
||Chairperson: Robert H. Eckel, MD
|12:55 - 1:10 pm
||Individualizing Treatment Strategies: Stratifying Cardiometabolic Risk in Obese Patients
||Presenter: Jamy D. Ard, MD
|1:10 - 1:30 pm
||How the Gut Talks to the Brain: Clinical Implications for Weight Loss
||Presenter: George A. Bray, MD
|1:30 - 1:50 pm
||Advances in Therapeutic Interventions for Weight Loss: What Is the Evidence and Where Are We Going?
||Presenter: Michael D. Jensen, MD
|1:50 - 2:15 pm
||Expert Strategies to Optimize the Management of the Obese Patient and Reduce Cardiometabolic Risk
Interactive Panel Discussion, Case Presentations, and Audience Q&A
||Moderator: Robert H. Eckel, MD
Case presenters & discussants: Jamy D. Ard, MD; George A. Bray, MD; Michael D. Jensen, MD
Jamy D. Ard, MD
Assoc. Professor, Div of Public Health Sciences
Dept. of Epidemiology & Prevention
Wake Forest School of Medicine
Co-Director, Weight Management Center
Medical Director, Medical Weight Loss Program
Wake Forest Baptist Health
George A. Bray, MD
- Boyd Professor
- Chief, Division of Clinical Obesity and Metabolism
- Pennington Biomedical Research Center
Robert H. Eckel, MD
Professor of Medicine
Division of Endocrinology, Metabolism and Diabetes
Division of Cardiology
Professor of Physiology and Biophysics
Charles A. Boettcher II Chair in Atherosclerosis
Director, T32 in Obesity and Cardiovascular Disease
University of Colorado Anschutz Medical Campus
Director, Lipid Clinic, University Hospital
Michael D. Jensen, MD
- Thomas J. Watson, Jr. Professor
- in Honor of Dr. Robert L. Frye
- Mayo College of Medicine
- Director, Dept. of Medicine
- Obesity Treatment Research Program
- Mayo Clinic
View Complete Accreditation Details and Program Overview: CMHC Accreditation